Broadwood Partners, L.P. Staar Surgical CO (STAA) insider trading activity

Broadwood Partners, L.P. is > 10% Shareholder of STAAR SURGICAL CO. Currently has a direct ownership of 10.8 Million shares of STAA, which is worth approximately $261 Million. The most recent transaction as insider was on Feb 11, 2021, when has been sold 7,412 shares (Common Stock) at a price of $124.51 per share, resulting in proceeds of $922,868. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.8M

0.74% 3M change

2.95% 12M change

Total Value Held $261 Million

BROADWOOD PARTNERS, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 11 2021	SELL Open market or private sale	$922,868 $124.51 p/Share	7,412 Reduced 0.08%	9,566,341 Common Stock
Feb 10 2021	SELL Open market or private sale	$972,846 $124.9 p/Share	7,789 Reduced 0.08%	9,573,753 Common Stock
Feb 09 2021	SELL Open market or private sale	$8,075,901 $124.09 p/Share	65,081 Reduced 0.67%	9,581,542 Common Stock
Feb 08 2021	SELL Open market or private sale	$17,710,790 $122.28 p/Share	144,838 Reduced 1.48%	9,646,623 Common Stock
Feb 05 2021	SELL Open market or private sale	$5,537,493 $116.09 p/Share	47,700 Reduced 0.48%	9,791,461 Common Stock
Feb 04 2021	SELL Open market or private sale	$5,411,560 $111.15 p/Share	48,687 Reduced 0.49%	9,839,161 Common Stock
Feb 03 2021	SELL Open market or private sale	$1,169,007 $110.44 p/Share	10,585 Reduced 0.11%	9,887,848 Common Stock
Feb 02 2021	SELL Open market or private sale	$175,298 $110.32 p/Share	1,589 Reduced 0.02%	9,898,433 Common Stock
Jan 28 2021	SELL Open market or private sale	$29,441,589 $105.83 p/Share	278,197 Reduced 2.73%	9,900,022 Common Stock
Jan 27 2021	SELL Open market or private sale	$17,125,697 $103.99 p/Share	164,686 Reduced 1.59%	10,178,219 Common Stock
Jan 26 2021	SELL Open market or private sale	$35,508,511 $102.33 p/Share	347,000 Reduced 3.25%	10,342,905 Common Stock
Jan 12 2021	SELL Open market or private sale	$5,356,800 $89.28 p/Share	60,000 Reduced 0.56%	10,689,905 Common Stock
Jan 04 2021	SELL Other acquisition or disposition	-	45,443 Reduced 0.42%	10,749,905 Common Stock
Jul 01 2020	SELL Other acquisition or disposition	-	4,062 Reduced 0.04%	10,795,348 Common Stock
Jan 02 2020	SELL Other acquisition or disposition	-	41,220 Reduced 0.38%	10,799,410 Common Stock
May 03 2019	BUY Open market or private purchase	$2,223,000 $22.23 p/Share	100,000 Added 0.91%	10,840,630 Common Stock
Oct 01 2018	SELL Other acquisition or disposition	-	114,549 Reduced 1.06%	10,740,630 Common Stock

Also insider at

LCTX

Lineage Cell Therapeutics, Inc. Healthcare

Director

CMRO

COMARCO INC

> 10% Shareholder

OCX

Oncocyte Corp Healthcare

> 10% Shareholder

BPL